IDXX
IDEXX Laboratories Inc.
Company Overview
| Mkt Cap | $50.50B | Price | $629.51 |
| Volume | 974.39K | Change | +0.15% |
| P/E Ratio | 56.9 | Open | $634.51 |
| Revenue | $3.9B | Prev Close | $628.54 |
| Net Income | $887.9M | 52W Range | $356.14 - $688.12 |
| Div Yield | N/A | Target | $722.36 |
| Overall | 37 | Value | 35 |
| Quality | -- | Technical | 40 |
No chart data available
Stock Overview
Updated DailyIDEXX Laboratories Inc. (IDXX) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $629.51 with a market capitalization of $50.50 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows IDXX with a volume of 974K shares. The stock opened up 0.95% from yesterday's close of $628.54. Current analyst estimates project earnings of $12.61 per share for this year, with next year targeting $14.16.
IDXX demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including NEOG, WOOF, HSKA, HSIC, ABT.
Key investment considerations for IDXX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 14.7%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:46 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IDXX | $629.51 | +0.2% | 974.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |